Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CME GROUP INC.CME · Entity 2909 | Director | September 25, 2026 | September 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CME GROUP INC.
Report date September 25, 2026 · Filed September 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock Class ASEC Table I · non-derivative | Direct | 1,067 |
Reported balance
After 2026-08-18 transaction · row 1
1 source rowRow 1 · 2026-08-18 · Other · Disposed 2,553.779 · Balance 1,067 F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 262,996.092 |
Reported balance
After 2026-08-18 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-08-18 · Other · Acquired 2,553.779 · Balance 262,996.092 F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934. |
| Common Stock Class ASEC Table I · non-derivative | Indirectby Trust | 263,288.642 |
Reported balance
After 2026-09-25 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-09-25 · Purchase · Acquired 292.55 · Balance 263,288.642 F2: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a change in the form of beneficial ownership from direct to indirect ownership via transfer to the Reporting Person's revocable living trust. This transaction is exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934.
F2: Represents shares acquired pursuant to a broker-administered dividend reinvestment plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 28, 2022 Filed Mar 29, 2023 23:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 289.366 | $168.11 | $48,645.32 |
DisclosureSEC source: 0001156375-23-000055 · wf-form4a_168013079174839.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Trust Disclosed balance after: 248,132.061 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| December 28, 2022 Filed Mar 29, 2023 23:00 UTC Amendment | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 12.757 | $168.11 | $2,144.58 |
DisclosureSEC source: 0001156375-23-000055 · wf-form4a_168013079174839.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,157.288 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker. Read SEC document |
| November 04, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 8,645 | $170.00 | $1,469,636.17 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 6 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 247,842.695 Read SEC document |
| November 04, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 40,000 | $170.00 | $6,800,000.00 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 5 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 239,197.695 Read SEC document |
| September 27, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 11.788 | $180.93 | $2,132.80 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,144.531 F1 · kind: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| June 27, 2022 Filed Jun 29, 2022 14:32 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,146 | $209.44 | $240,018.24 |
DisclosureSEC source: 0001156375-22-000199 · wf-form4_165651314951555.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 199,197.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 27, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 10.057 | $211.06 | $2,122.63 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,132.743 F1 · kind: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 25, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 8.608 | $245.59 | $2,114.04 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,122.686 F1 · kind: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| January 25, 2022 Filed Jan 26, 2022 20:20 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 75 | $221.79 | $16,634.25 |
DisclosureSEC source: 0001156375-22-000023 · wf-form4_164322839155038.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 198,051.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| January 14, 2022 Filed Nov 9, 2022 00:28 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 30.347 | $222.28 | $6,745.53 |
DisclosureSEC source: 0001156375-22-000318 · wf-form4_166795372060289.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,114.078 F1 · kind: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| December 28, 2021 Filed Nov 8, 2022 22:33 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 8.139 | $229.52 | $1,868.06 |
DisclosureSEC source: 0001156375-22-000316 · wf-form5_166794679347775.xml · nonDerivative · entry 5 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,083.731 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| September 27, 2021 Filed Nov 8, 2022 22:33 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 9.369 | $198.48 | $1,859.56 |
DisclosureSEC source: 0001156375-22-000316 · wf-form5_166794679347775.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,075.592 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 25, 2021 Filed Jun 30, 2021 01:15 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 917 | $218.12 | $200,016.04 |
DisclosureSEC source: 0001156375-21-000082 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 197,976.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2021 Filed Nov 8, 2022 22:33 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 8.511 | $217.60 | $1,851.99 |
DisclosureSEC source: 0001156375-22-000316 · wf-form5_166794679347775.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,066.223 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| March 25, 2021 Filed Nov 8, 2022 22:33 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 9.044 | $203.88 | $1,843.89 |
DisclosureSEC source: 0001156375-22-000316 · wf-form5_166794679347775.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,057.712 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| January 13, 2021 Filed Nov 8, 2022 22:33 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 24.871 | $202.48 | $5,035.88 |
DisclosureSEC source: 0001156375-22-000316 · wf-form5_166794679347775.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,048.668 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| December 29, 2020 Filed Nov 8, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 9.454 | $181.11 | $1,712.21 |
DisclosureSEC source: 0001156375-22-000314 · wf-form5_166794671094843.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,023.797 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| September 25, 2020 Filed Nov 8, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 10.411 | $163.61 | $1,703.34 |
DisclosureSEC source: 0001156375-22-000314 · wf-form5_166794671094843.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,014.343 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 25, 2020 Filed Jun 29, 2020 22:14 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,186 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-20-000067 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 197,059.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 25, 2020 Filed Nov 8, 2022 22:32 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 3.932 | $166.66 | $655.31 |
DisclosureSEC source: 0001156375-22-000314 · wf-form5_166794671094843.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,003.932 F1 · kind: Acquisition of shares under a broker-administered dividend reinvestment plan. Read SEC document |
| June 11, 2020 Filed Jun 12, 2020 15:44 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 1,229 | $178.10 | $218,884.90 |
DisclosureSEC source: 0001156375-20-000049 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Read SEC document |
| June 02, 2020 Filed Jun 4, 2020 23:52 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 771 | $178.10 | $137,315.10 |
DisclosureSEC source: 0001156375-20-000045 · primary_doc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 771 Read SEC document |
| June 25, 2019 Filed Jun 27, 2019 19:38 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,009 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-19-000074 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 195,873.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| September 25, 2018 Filed Sep 27, 2018 21:15 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 173 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000117 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 194,864.695 F1 · shares: Incremental grant made pursuant to the CME Group Director Stock Plan, as amended and restated, as a result of an increase to Board compensation. Read SEC document |
| June 25, 2018 Filed Jun 27, 2018 17:42 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 961 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-18-000071 · edgardoc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · by Trust Disclosed balance after: 194,691.695 F1 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| June 26, 2017 Filed Jun 27, 2017 21:58 UTC | CME GROUP INC. CME · Entity 2909 | GrantCommon Stock Class A | 1,294 | $0.00 | $0.00 |
DisclosureSEC source: 0001156375-17-000061 · primary_doc.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,108 F3 · kind: Granted pursuant to the CME Group Director Stock Plan, as amended and restated. Read SEC document |
| May 31, 2016 Filed Jun 27, 2017 21:58 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 100 | $97.78 | $9,778.00 |
DisclosureSEC source: 0001156375-17-000061 · primary_doc.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,814 F2 · kind: This line item is added to report a delinquent transaction for the purchase of 100 shares on May 31, 2016. Read SEC document |
| December 29, 2014 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 155.2 | $90.34 | $14,020.77 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 18 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,338.69 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| September 26, 2014 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 175.43 | $79.46 | $13,939.67 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 17 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,183.49 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| June 26, 2014 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 197.96 | $69.65 | $13,787.91 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 16 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,008.06 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| March 26, 2014 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 180.47 | $76.25 | $13,760.84 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 15 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,810.1 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| December 27, 2013 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 164.12 | $79.83 | $13,101.70 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 14 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,629.63 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| September 30, 2013 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 173.55 | $75.04 | $13,023.19 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 13 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,465.51 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| June 26, 2013 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 169.78 | $76.26 | $12,947.42 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 12 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,291.96 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| March 26, 2013 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 209.19 | $61.44 | $12,852.63 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 11 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,122.17 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| December 27, 2012 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 252.99 | $50.36 | $12,740.58 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 10 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,912.98 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| September 28, 2012 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 116.22 | $53.19 | $6,181.74 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,340.4 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| September 26, 2012 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 222.29 | $56.86 | $12,639.41 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 9 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,659.99 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. Read SEC document |
| June 26, 2012 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 231.5 | $53.67 | $12,424.61 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 8 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,437.7 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| March 26, 2012 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 207.96 | $59.30 | $12,332.03 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 7 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,206.2 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| March 12, 2012 Filed Jun 27, 2017 21:58 UTC | CME GROUP INC. CME · Entity 2909 | PurchaseCommon Stock Class A | 375 | $54.25 | $20,343.75 |
DisclosureSEC source: 0001156375-17-000061 · primary_doc.xml · nonDerivative · entry 1 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,714 F1 · kind: This line item is added to report a delinquent transaction for the purchase of 75 shares on March 12, 2012, adjusted to an aggregate of 375 shares to reflect a 5 for 1 stock split. Read SEC document |
| December 31, 2011 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 158.23 | $48.65 | $7,697.89 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 6 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,998.24 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| September 27, 2011 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 142.06 | $53.90 | $7,657.03 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 5 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,840.01 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| June 28, 2011 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 134.3 | $56.74 | $7,620.18 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 4 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,697.95 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| March 28, 2011 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 128.19 | $59.16 | $7,583.72 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 3 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,563.64 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
| December 28, 2010 Filed Feb 15, 2017 00:07 UTC | CME GROUP INC. CME · Entity 2909 | OtherCommon Stock Class A | 95.05 | $65.31 | $6,207.72 |
DisclosureSEC source: 0001156375-17-000012 · primary_doc.xml · nonDerivative · entry 2 SHEPARD WILLIAM R · CIK 0001212852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,435.45 F1 · kind: This Form 5 is being filed to correct the number of shares of CME Group Class A common stock beneficially held by Mr. Shepard. Mr. Shepard acquired a total of 3,114.51 shares of CME Group Class A common stock under a broker directed dividend reinvestment plan (DRIP) on a quarterly basis from 9/28/2010 through 12/29/2014. His total direct ownership, including 3,114.51 shares, is 55,338.69. F2 · shares: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. F2 · price: Adjusted to account for a subsequent 5 to 1 stock split to reflect current ownership and cost. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.